Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2015
Refining the definition of clinically important mineral and bone disorder in hemodialysis patientsMark D Danese, Marc Halperin, Kimberly A Lowe, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 5, 2020
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trialGeoffrey A Block, Glenn M Chertow, Kerry Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 11, 2014
Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKDKeitaro Yokoyama, Hideki Hirakata, Takashi Akiba, et al.
International Journal of Nephrology|April 21, 2012
Impact of hemodialysis catheter dysfunction on dialysis and other medical services: an observational cohort studyRobert I Griffiths, Britt B Newsome, Grace Leung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006Wendy L St Peter, Qi Li, Jiannong Liu, et al.
Atherosclerosis|October 8, 2016
Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosisPaola Ciceri, Francesca Elli, Paola Braidotti, et al.
American Journal of Nephrology|November 28, 2014
Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysisAnna T Mathew, Azzour Hazzan, Kenar D Jhaveri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 25, 2014
Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equationCassianne Robinson-Cohen, Joachim H Ix, Gerard Smits, et al.
Kidney International|June 18, 2010
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patientsGeoffrey A Block, David Zaun, Gerard Smits, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2015
Refining the definition of clinically important mineral and bone disorder in hemodialysis patientsMark D Danese, Marc Halperin, Kimberly A Lowe, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 5, 2020
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trialGeoffrey A Block, Glenn M Chertow, Kerry Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 11, 2014
Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKDKeitaro Yokoyama, Hideki Hirakata, Takashi Akiba, et al.
International Journal of Nephrology|April 21, 2012
Impact of hemodialysis catheter dysfunction on dialysis and other medical services: an observational cohort studyRobert I Griffiths, Britt B Newsome, Grace Leung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006Wendy L St Peter, Qi Li, Jiannong Liu, et al.
Atherosclerosis|October 8, 2016
Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosisPaola Ciceri, Francesca Elli, Paola Braidotti, et al.
American Journal of Nephrology|November 28, 2014
Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysisAnna T Mathew, Azzour Hazzan, Kenar D Jhaveri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 25, 2014
Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equationCassianne Robinson-Cohen, Joachim H Ix, Gerard Smits, et al.
Kidney International|June 18, 2010
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patientsGeoffrey A Block, David Zaun, Gerard Smits, et al.
Pageof 12